Devleeschouwer MJ - Search Results

1

In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.

Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ. Tré-Hardy M, et al. Among authors: devleeschouwer mj. Int J Antimicrob Agents. 2008 Apr;31(4):329-36. doi: 10.1016/j.ijantimicag.2007.12.005. Epub 2008 Feb 14. Int J Antimicrob Agents. 2008. PMID: 18280117

2

Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.

Tré-Hardy M, Macé C, El Manssouri N, Vanderbist F, Traore H, Devleeschouwer MJ. Tré-Hardy M, et al. Among authors: devleeschouwer mj. Int J Antimicrob Agents. 2009 Jan;33(1):40-5. doi: 10.1016/j.ijantimicag.2008.07.012. Epub 2008 Sep 17. Int J Antimicrob Agents. 2009. PMID: 18801647

3

Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ. Tré-Hardy M, et al. Among authors: devleeschouwer mj. Int J Antimicrob Agents. 2009 Oct;34(4):370-4. doi: 10.1016/j.ijantimicag.2009.04.010. Epub 2009 Jun 7. Int J Antimicrob Agents. 2009. PMID: 19505804

4

Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.

Nagant C, Tré-Hardy M, El-Ouaaliti M, Savage P, Devleeschouwer M, Dehaye JP. Nagant C, et al. Appl Microbiol Biotechnol. 2010 Sep;88(1):251-63. doi: 10.1007/s00253-010-2748-3. Epub 2010 Jul 13. Appl Microbiol Biotechnol. 2010. PMID: 20625718

5

Study of the initial phase of biofilm formation using a biofomic approach.

Nagant C, Tré-Hardy M, Devleeschouwer M, Dehaye JP. Nagant C, et al. J Microbiol Methods. 2010 Sep;82(3):243-8. doi: 10.1016/j.mimet.2010.06.011. Epub 2010 Jul 27. J Microbiol Methods. 2010. PMID: 20603162

6

Modulation by LL-37 of the responses of salivary glands to purinergic agonists.

Pochet S, Tandel S, Querriére S, Tre-Hardy M, Garcia-Marcos M, De Lorenzi M, Vandenbranden M, Marino A, Devleeschouwer M, Dehaye JP. Pochet S, et al. Mol Pharmacol. 2006 Jun;69(6):2037-46. doi: 10.1124/mol.105.021444. Epub 2006 Mar 2. Mol Pharmacol. 2006. PMID: 16514052

7

Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance.

Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Traore H, et al. Int J Tuberc Lung Dis. 2000 May;4(5):481-4. Int J Tuberc Lung Dis. 2000. PMID: 10815743

8

Influence of protamine on the in vitro sensitivity of Pseudomonas aeruginosa to antibiotics.

Boussard P, Devleeschouwer M, Dony J. Boussard P, et al. Pharm Acta Helv. 1994 Jan;68(3):161-7. doi: 10.1016/0031-6865(94)90038-8. Pharm Acta Helv. 1994. PMID: 8121924

9

Study of the formation of a biofilm by clinical strains of Staphylococcus aureus.

Liesse Iyamba JM, Seil M, Devleeschouwer M, Takaisi Kikuni NB, Dehaye JP. Liesse Iyamba JM, et al. Biofouling. 2011 Sep;27(8):811-21. doi: 10.1080/08927014.2011.604776. Biofouling. 2011. PMID: 21810033

10

Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982.

Allemeersch D, Beumer J, Devleeschouwer M, De Maeyer S, Dony J, Godard C, Osterrieth P, Pithsy A, Van der Auwera P, Van Poppel H, et al. Allemeersch D, et al. Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):265-9. doi: 10.1007/BF01963099. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3134229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page